APO RESEARCH · REPORT
Competent Cells
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Product & engineering
Understand the product.
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Selected research
Industry Growth & Trends
Global Competent Cells Industry Growth and Trends Forecast to 2032
Market perspective
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
According to APO Research, the global Competent Cells market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Competent Cells market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Competent Cells market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Competent Cells market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Competent Cells.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Competent Cells market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Competent Cells Market by Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems
Competent Cells Segment by Type
Chemically Competent Cells
Electrocompetent Cells
Competent Cells Segment by Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded DNA Production
Bacmid Creation
Cre-Lox Recombination (PIR1/PIR2)
Competent Cells Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Competent Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Competent Cells companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Chemically Competent Cells
- Electrocompetent Cells
Applications
- Subcloning & Routine Cloning
- Phage Display Library Construction
- Toxic/Unstable DNA Cloning
- High-Throughput Cloning
- Protein Expression
- Mutagenesis
- Single-Stranded DNA Production
- Bacmid Creation
- Cre-Lox Recombination (PIR1/PIR2)
Companies covered
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Takara Bio
- Promega Corporation
- Beijing TransGen Biotech
- GeneScript Corporation
- Yeastern Biotech
- New England Biolabs
- QIAGEN N.V.
- OriGene Technologies
- Lucigen
- Zymo Research
- Bio-Rad Laboratories
- Bioline
- Delphi Genetics
- IBA GmBH
- Cell Applications
- BioDynamics Laboratory
- Scarab Genomics
- GCC Biotech
- SMOBIO Technology
- Edge BioSystems
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Competent Cells Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Competent Cells Market Size by Region (2021-2032)
- 1.4.1 Global Competent Cells Market Size by Region (2021-2026)
- 1.4.2 Global Competent Cells Market Size by Region (2027-2032)
- 1.5 Key Regions Competent Cells Market Size (2021-2032)
- 1.5.1 North America Competent Cells Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Competent Cells Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Competent Cells Market Size Growth Rate (2021-2032)
- 1.5.4 South America Competent Cells Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Competent Cells Market Size Growth Rate (2021-2032)
2 Competent Cells Market by Type
- 2.1 Type Introduction
- 2.1.1 Chemically Competent Cells
- 2.1.2 Electrocompetent Cells
- 2.2 Global Competent Cells Market Size by Type
- 2.2.1 Global Competent Cells Market Size Overview by Type (2021-2032)
- 2.2.2 Global Competent Cells Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Competent Cells Market Size Forecasted by Type (2027-2032)
- 2.3 Global Competent Cells Market Size by Regions
- 2.3.1 North America Competent Cells Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Competent Cells Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Competent Cells Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Competent Cells Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Competent Cells Market Size Breakdown by Type (2021-2026)
3 Competent Cells Market by Application
- 3.1 Type Introduction
- 3.1.1 Subcloning & Routine Cloning
- 3.1.2 Phage Display Library Construction
- 3.1.3 Toxic/Unstable DNA Cloning
- 3.1.4 High-Throughput Cloning
- 3.1.5 Protein Expression
- 3.1.6 Mutagenesis
- 3.1.7 Single-Stranded DNA Production
- 3.1.8 Bacmid Creation
- 3.1.9 Cre-Lox Recombination (PIR1/PIR2)
- 3.2 Global Competent Cells Market Size by Application
- 3.2.1 Global Competent Cells Market Size Overview by Application (2021-2032)
- 3.2.2 Global Competent Cells Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Competent Cells Market Size Forecasted by Application (2027-2032)
- 3.3 Global Competent Cells Market Size by Regions
- 3.3.1 North America Competent Cells Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Competent Cells Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Competent Cells Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Competent Cells Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Competent Cells Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Competent Cells Industry Trends
- 4.2 Competent Cells Industry Drivers
- 4.3 Competent Cells Industry Opportunities and Challenges
- 4.4 Competent Cells Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Competent Cells Revenue (2021-2026)
- 5.2 Global Competent Cells Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Competent Cells Key Company Headquarters & Area Served
- 5.4 Global Competent Cells Company, Product Type & Application
- 5.5 Global Competent Cells Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Competent Cells Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Competent Cells Players Market Share by Revenue in 2025
- 5.6.3 2025 Competent Cells Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Merck KGaA
- 6.1.1 Merck KGaA Company Information
- 6.1.2 Merck KGaA Business Overview
- 6.1.3 Merck KGaA Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Merck KGaA Competent Cells Product Portfolio
- 6.1.5 Merck KGaA Recent Developments
- 6.2 Thermo Fisher Scientific
- 6.2.1 Thermo Fisher Scientific Company Information
- 6.2.2 Thermo Fisher Scientific Business Overview
- 6.2.3 Thermo Fisher Scientific Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Thermo Fisher Scientific Competent Cells Product Portfolio
- 6.2.5 Thermo Fisher Scientific Recent Developments
- 6.3 Agilent Technologies
- 6.3.1 Agilent Technologies Company Information
- 6.3.2 Agilent Technologies Business Overview
- 6.3.3 Agilent Technologies Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Agilent Technologies Competent Cells Product Portfolio
- 6.3.5 Agilent Technologies Recent Developments
- 6.4 Takara Bio
- 6.4.1 Takara Bio Company Information
- 6.4.2 Takara Bio Business Overview
- 6.4.3 Takara Bio Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Takara Bio Competent Cells Product Portfolio
- 6.4.5 Takara Bio Recent Developments
- 6.5 Promega Corporation
- 6.5.1 Promega Corporation Company Information
- 6.5.2 Promega Corporation Business Overview
- 6.5.3 Promega Corporation Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Promega Corporation Competent Cells Product Portfolio
- 6.5.5 Promega Corporation Recent Developments
- 6.6 Beijing TransGen Biotech
- 6.6.1 Beijing TransGen Biotech Company Information
- 6.6.2 Beijing TransGen Biotech Business Overview
- 6.6.3 Beijing TransGen Biotech Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Beijing TransGen Biotech Competent Cells Product Portfolio
- 6.6.5 Beijing TransGen Biotech Recent Developments
- 6.7 GeneScript Corporation
- 6.7.1 GeneScript Corporation Company Information
- 6.7.2 GeneScript Corporation Business Overview
- 6.7.3 GeneScript Corporation Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GeneScript Corporation Competent Cells Product Portfolio
- 6.7.5 GeneScript Corporation Recent Developments
- 6.8 Yeastern Biotech
- 6.8.1 Yeastern Biotech Company Information
- 6.8.2 Yeastern Biotech Business Overview
- 6.8.3 Yeastern Biotech Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Yeastern Biotech Competent Cells Product Portfolio
- 6.8.5 Yeastern Biotech Recent Developments
- 6.9 New England Biolabs
- 6.9.1 New England Biolabs Company Information
- 6.9.2 New England Biolabs Business Overview
- 6.9.3 New England Biolabs Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 New England Biolabs Competent Cells Product Portfolio
- 6.9.5 New England Biolabs Recent Developments
- 6.10 QIAGEN N.V.
- 6.10.1 QIAGEN N.V. Company Information
- 6.10.2 QIAGEN N.V. Business Overview
- 6.10.3 QIAGEN N.V. Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 QIAGEN N.V. Competent Cells Product Portfolio
- 6.10.5 QIAGEN N.V. Recent Developments
- 6.11 OriGene Technologies
- 6.11.1 OriGene Technologies Company Information
- 6.11.2 OriGene Technologies Business Overview
- 6.11.3 OriGene Technologies Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 OriGene Technologies Competent Cells Product Portfolio
- 6.11.5 OriGene Technologies Recent Developments
- 6.12 Lucigen
- 6.12.1 Lucigen Company Information
- 6.12.2 Lucigen Business Overview
- 6.12.3 Lucigen Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Lucigen Competent Cells Product Portfolio
- 6.12.5 Lucigen Recent Developments
- 6.13 Zymo Research
- 6.13.1 Zymo Research Company Information
- 6.13.2 Zymo Research Business Overview
- 6.13.3 Zymo Research Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Zymo Research Competent Cells Product Portfolio
- 6.13.5 Zymo Research Recent Developments
- 6.14 Bio-Rad Laboratories
- 6.14.1 Bio-Rad Laboratories Company Information
- 6.14.2 Bio-Rad Laboratories Business Overview
- 6.14.3 Bio-Rad Laboratories Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Bio-Rad Laboratories Competent Cells Product Portfolio
- 6.14.5 Bio-Rad Laboratories Recent Developments
- 6.15 Bioline
- 6.15.1 Bioline Company Information
- 6.15.2 Bioline Business Overview
- 6.15.3 Bioline Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Bioline Competent Cells Product Portfolio
- 6.15.5 Bioline Recent Developments
- 6.16 Delphi Genetics
- 6.16.1 Delphi Genetics Company Information
- 6.16.2 Delphi Genetics Business Overview
- 6.16.3 Delphi Genetics Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Delphi Genetics Competent Cells Product Portfolio
- 6.16.5 Delphi Genetics Recent Developments
- 6.17 IBA GmBH
- 6.17.1 IBA GmBH Company Information
- 6.17.2 IBA GmBH Business Overview
- 6.17.3 IBA GmBH Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 IBA GmBH Competent Cells Product Portfolio
- 6.17.5 IBA GmBH Recent Developments
- 6.18 Cell Applications
- 6.18.1 Cell Applications Company Information
- 6.18.2 Cell Applications Business Overview
- 6.18.3 Cell Applications Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Cell Applications Competent Cells Product Portfolio
- 6.18.5 Cell Applications Recent Developments
- 6.19 BioDynamics Laboratory
- 6.19.1 BioDynamics Laboratory Company Information
- 6.19.2 BioDynamics Laboratory Business Overview
- 6.19.3 BioDynamics Laboratory Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 BioDynamics Laboratory Competent Cells Product Portfolio
- 6.19.5 BioDynamics Laboratory Recent Developments
- 6.20 Scarab Genomics
- 6.20.1 Scarab Genomics Company Information
- 6.20.2 Scarab Genomics Business Overview
- 6.20.3 Scarab Genomics Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Scarab Genomics Competent Cells Product Portfolio
- 6.20.5 Scarab Genomics Recent Developments
- 6.21 GCC Biotech
- 6.21.1 GCC Biotech Company Information
- 6.21.2 GCC Biotech Business Overview
- 6.21.3 GCC Biotech Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 GCC Biotech Competent Cells Product Portfolio
- 6.21.5 GCC Biotech Recent Developments
- 6.22 SMOBIO Technology
- 6.22.1 SMOBIO Technology Company Information
- 6.22.2 SMOBIO Technology Business Overview
- 6.22.3 SMOBIO Technology Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 SMOBIO Technology Competent Cells Product Portfolio
- 6.22.5 SMOBIO Technology Recent Developments
- 6.23 Edge BioSystems
- 6.23.1 Edge BioSystems Company Information
- 6.23.2 Edge BioSystems Business Overview
- 6.23.3 Edge BioSystems Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Edge BioSystems Competent Cells Product Portfolio
- 6.23.5 Edge BioSystems Recent Developments
7 North America
- 7.1 North America Competent Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Competent Cells Market Size by Country (2021-2026)
- 7.3 North America Competent Cells Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Competent Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Competent Cells Market Size by Country (2021-2026)
- 8.3 Europe Competent Cells Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Competent Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Competent Cells Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Competent Cells Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Competent Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Competent Cells Market Size by Country (2021-2026)
- 10.3 South America Competent Cells Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Competent Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Competent Cells Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Competent Cells Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst